Atossa Therapeutics founder to be selected as NIAID director — report
Steven Quay, the founder and CEO of clinical-stage biotech Atossa Therapeutics, is likely to be the next director of NIH's National Institute of Allergy and Infectious Diseases, according to a news report. Quay also authored ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.





